News

Lumos Diagnostics' shares more than doubled in value in afternoon trade after the biotech announced a US$317 million ($487 ...
Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research repo ...
Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...
NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...
Detailed price information for Salarius Pharmaceuticals Inc (SLRX-Q) from The Globe and Mail including charting and trades.